AstraZeneca: all 4,196 studies
Page 8 of 42. Open to participants first (299), then studies with results posted, then the rest; newest registration first within each.
- A Phase I Study to Assess PK of AZD7986 Alone & With Verapamil, Itraconazole or Diltiazem in Healthy SubjectsCompletedNCT02653872Phase 1Results posted
- A Study to Assess the Bioavailability and to Compare the Pharmacokinetics of AZD7594 Inhaled Via Monodose Inhaler and Multiple-dose Dry Powder Inhalers (DPI) or Pressurized Metered-dose Inhaler (pMDI) in Healthy Male SubjectsCompletedNCT02648438Phase 1Results posted
- A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD7594 Inhaled Formulation in Healthy Japanese MenCompletedNCT02645253Phase 1Results posted
- A Study to Assess the Effects of PT003 and Placebo MDI on Specific Image Based Airway Volumes and Resistance in Subjects With Moderate to Severe COPDCompletedNCT02643082Phase 3Results posted
- Absorption, Metabolism, Excretion and Pharmacokinetics of a Single Dose [14C]AZD2014 Followed by a Multiple Dose PhaseCompletedNCT02640755Phase 1Results posted
- A Study to Assess the Bioequivalence of Dapagliflozin/Metformin XR Fixed-dose Combination Tablets in Healthy SubjectsCompletedNCT02637037Phase 1Results posted
- A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD5718 After Single and Multiple Ascending Dose Administration to Healthy Male SubjectsCompletedNCT02632526Phase 1Results posted
- A Open Label Study in Previously Studied, SBC-103 Treatment Naïve MPS IIIB Subjects to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics/Efficacy of SBC-103 Administered IntravenouslyTerminatedNCT02618512Phase 1/2Results posted
- Evaluation of Potential Predictors of Disease Progression in Participants With Atypical Hemolytic Uremic Syndrome (aHUS) Including Genetics, Biomarkers, and TreatmentTerminatedNCT02614898Results posted
- POtassium and Cardiac Rhythm Trends in MaintENance HemoDialysis: A Multicenter, Prospective, Observational StudyCompletedNCT02609841Results posted
- Open-label, Multiple Ascending Dose Study of Ravulizumab (ALXN1210) in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH)CompletedNCT02605993Phase 2Results posted
- A Phase 2a to Evaluate the Safety of MEDI8852 in Adults With Uncomplicated InfluenzaCompletedNCT02603952Phase 1/2Results posted
- A Study to Assess the Pharmacokinetics and Safety of Single Doses of Anifrolumab in Healthy SubjectsCompletedNCT02601625Phase 1Results posted
- To Evaluate Safety, Pharmacokinetics and Pharmacodynamics of MEDI6012 in Subjects With Stable Coronary Artery DiseaseCompletedNCT02601560Phase 2Results posted
- Dose-Escalation Study of ALXN1210 IV in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH)CompletedNCT02598583Phase 1/2Results posted
- A Phase 1b/2, Multicenter, Open-label Study of ACP-196 in Subjects With Recurrent Glioblastoma Multiforme (GBM)Active, not recruitingNCT02586857Phase 1/2Results posted
- Phase Ib/II Study of MEDI4736 Evaluated in Different Combinations in Metastatic Pancreatic Ductal CarcinomaCompletedNCT02583477Phase 1/2Results posted
- The PK and PD of Dapagliflozin Therapy in Combination With Insulin in Japanese Subjects With T1DMCompletedNCT02582840Phase 1Results posted
- The Safety and Efficacy of Dapagliflozin Therapy in Combination With Insulin in Japanese Subjects With T1DMCompletedNCT02582814Phase 3Results posted
- Evaluation of Efficacy and Safety of Brazikumab (MEDI2070) in Participants With Active, Moderate to Severe Crohn's DiseaseTerminatedNCT02574637Phase 2Results posted
- Two-part Safety, Tolerability, Pharmacodynamic and -Kinetic Study of Inhaled AZD8871 in Asthmatic and COPD SubjectsCompletedNCT02573155Phase 1Results posted
- Phase 2, Nab Paclitaxel/Gemcitabine Alone and in Combination With ACP-196 in Subjects With Metastatic Pancreatic CancerTerminatedNCT02570711Phase 2Results posted
- A Drug-drug Interaction Study of Lanabecestat (LY3314814) in Healthy ParticipantsCompletedNCT02568397Phase 1Results posted
- Foxiga Korea Local Phase 4 StudyCompletedNCT02564926Phase 4Results posted
- A Phase I, Open-Label, 2 Part Multicentre Study to Assess the Safety and Efficacy of Olaparib in Combination With Carboplatin in Patients With Advanced HER-2 Negative Breast CancerTerminatedNCT02561832Phase 1Results posted
- Phase II Study of MEDI4736 Monotherapy or in Combinations With Tremelimumab in Metastatic Pancreatic Ductal CarcinomaCompletedNCT02558894Phase 2Results posted
- A 24-week Open-Label, Phase 3b Trial With a 28-week Extension to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin Compared to Insulin Glargine in Subjects withType 2 Diabetes Who Have Glycemic Control on MetforminCompletedNCT02551874Phase 3Results posted
- Phase III Open Label Study of MEDI 4736 With/Without Tremelimumab Versus Standard of Care (SOC) in Recurrent/Metastatic Head and Neck CancerCompletedNCT02551159Phase 3Results posted
- A Multiple-ascending-dose Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of MEDI0382 in Overweight and Obese Participants With Type 2 Diabetes MellitusCompletedNCT02548585Phase 1/2Results posted
- A Study to Evaluate the Effect of Dapagliflozin With and Without Saxagliptin on Albuminuria, and to Investigate the Effect of Dapagliflozin and Saxagliptin on HbA1c in Patients With Type 2 Diabetes and CKDCompletedNCT02547935Phase 2/3Results posted
- Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus NephritisCompletedNCT02547922Phase 2Results posted
- A phase3 Study Measuring the Effect of Rosuvastatin 20 mg on Carotid Intima-Media Thickness in Chinese Subjects With Subclinical AtherosclerosisCompletedNCT02546323Phase 3Results posted
- Study of Durvalumab With Tremelimumab Versus SoC as 1st Line Therapy in Metastatic Non Small-Cell Lung Cancer (NSCLC) (NEPTUNE)Active, not recruitingNCT02542293Phase 3Results posted
- A Drug Interaction Study of Lanabecestat (LY3314814) and Warfarin in Healthy ParticipantsCompletedNCT02540668Phase 1Results posted
- Acalabrutinib (ACP-196) Alone and in Combination With Pembrolizumab in Ovarian Cancer (KEYNOTE191)CompletedNCT02537444Phase 2Results posted
- Study to Assess the Safety and Tolerability of PT010, PT009 and PT003 in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary DiseaseCompletedNCT02536508Phase 3Results posted
- Phase IV O2 Consumption Study in COPD Patients.CompletedNCT02533505Phase 4Results posted
- A 12/24-weeks, Open, Multi-centre, Phase IV Study on Safety and Efficacy of 2mg Exenatide Once Weekly (Bydureon) in T2DM Patients.CompletedNCT02533453Phase 4Results posted
- A Study to Assess the Pharmacodynamic Effect of Single Doses of AZD9977 in Healthy Male SubjectsCompletedNCT02532998Phase 1Results posted
- Post-approval Clinical Study of Asfotase Alfa Treatment for Patients With Hypophosphatasia (HPP) in JapanCompletedNCT02531867Phase 4Results posted
- Phase I, Study in Chinese NSCLC PatientsCompletedNCT02529995Phase 1Results posted
- Study of Tremelimumab in Patients With Advanced Solid TumorsCompletedNCT02527434Phase 2Results posted
- Phase 2a Study to Evaluate the Efficacy and Safety of MEDI9929 in Adults With Atopic DermatitisCompletedNCT02525094Phase 2Results posted
- A Study of Durvalumab or Tremelimumab Monotherapy, or Durvalumab in Combination With Tremelimumab or Bevacizumab in Advanced Hepatocellular CarcinomaActive, not recruitingNCT02519348Phase 2Results posted
- Study of MEDI4736 (Durvalumab) With or Without Tremelimumab Versus Standard of Care Chemotherapy in Urothelial CancerActive, not recruitingNCT02516241Phase 3Results posted
- A Study to Evaluate the Pharmacokinetics of MEDI9929 (AMG 157) in Adolescents With Mild to Moderate AsthmaCompletedNCT02512900Phase 1Results posted
- A Single Ascending Dose Study To Assess The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of AZD9567.CompletedNCT02512575Phase 1Results posted
- AZD9291 Versus Placebo in Patients With Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy.Active, not recruitingNCT02511106Phase 3Results posted
- A Study to Evaluate the Efficacy of MEDI7510 in Older AdultsTerminatedNCT02508194Phase 2Results posted
- Effect of a Fixed Pramlintide: Insulin Dose Ratio on Postprandial Glucose in Type 1 Diabetes MellitusCompletedNCT02500979Phase 1Results posted
- Study to Assess MEDI4736 With Either AZD9150 or AZD5069 in Advanced Solid Tumors & Relapsed Metastatic Squamous Cell Carcinoma of Head & NeckCompletedNCT02499328Phase 1/2Results posted
- Phase 2a RDEA3170 and Allopurinol Combination Study in Gout SubjectsCompletedNCT02498652Phase 2Results posted
- A Randomized, Double-Blind, Parallel-Group, 24-Week, Chronic-Dosing, Multi-Center Study to Assess the Efficacy and Safety of PT010, PT003, and PT009 Compared With Symbicort® Turbuhaler® (Kronos)CompletedNCT02497001Phase 3Results posted
- A Phase I, Open-label Study to Assess Bioavailability of a Single Oral Dose of AZD9291 vs an IV Dose of [14C]AZD9291CompletedNCT02491944Phase 1Results posted
- A Study in Asthma Patients to Evaluate Efficacy, Safety and Tolerability of 14 Days Once Daily Inhaled Interferon Beta-1a After the Onset of Symptoms of an Upper Respiratory Tract InfectionCompletedNCT02491684Phase 2Results posted
- A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD9977 After Single Ascending Doses to Healthy MalesCompletedNCT02484729Phase 1Results posted
- A Study to Assess the Effect of Ticagrelor in Reducing the Number of Days With Pain in Patients With Sickle Cell DiseaseCompletedNCT02482298Phase 2Results posted
- A Multiple Dosing (14 Days) Study to Assess Efficacy and Safety of Three Dose Levels of AZD7594, Given Once Daily by Inhalation, in Patients With Mild to Moderate AsthmaCompletedNCT02479412Phase 2Results posted
- Study of Acalabrutinib (ACP-196) Versus Ibrutinib in Previously Treated Participants With High Risk Chronic Lymphocytic Leukemia (CLL)Active, not recruitingNCT02477696Phase 3Results posted
- To Assess the Efficacy and Safety of Olaparib Maintenance Monotherapy in the Treatment of Ovarian CancerCompletedNCT02476968Phase 4Results posted
- Acalabrutinib, Obinutuzumab and Chlorambucil in Treatment naïve CLLCompletedNCT02475681Phase 3Results posted
- Real World Treatment Study of AZD9291 for Advanced/Metastatic EGFR T790M Mutation NSCLCCompletedNCT02474355Phase 3Results posted
- Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults for the 2015-2016 SeasonCompletedNCT02473510Phase 4Results posted
- Efficacy and Safety of Dapagliflozin and Dapagliflozin Plus Saxagliptin in Combination With Metformin in Type 2 Diabetes Patients Compared With SulphonylureaCompletedNCT02471404Phase 4Results posted
- Study to Assess the Efficacy and Safety of PT010 Relative to PT003 and PT009 in Subjects With Moderate to Very Severe COPD (Ethos)CompletedNCT02465567Phase 3Results posted
- AZD0585 Phase III Long-term Study in JapanCompletedNCT02463071Phase 3Results posted
- Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 DiabetesCompletedNCT02460978Phase 3Results posted
- Crossover Study to Assess the Efficacy of PT003 With and Without a Valved Holding Chamber in Subjects With Moderate to Severe COPDCompletedNCT02454959Phase 3Results posted
- Study of AZD9291 Plus MEDI4736 Versus AZD9291 Monotherapy in NSCLC After Previous EGFR TKI Therapy in T790M Mutation Positive TumoursCompletedNCT02454933Phase 3Results posted
- Study of the Combination of Acalabrutinib (ACP-196) and Pembrolizumab in Advanced Head and Neck Squamous Cell CarcinomaCompletedNCT02454179Phase 2Results posted
- Phase III Open Label First Line Therapy Study of MEDI 4736 (Durvalumab) With or Without Tremelimumab Versus SOC in Non Small-Cell Lung Cancer (NSCLC)Active, not recruitingNCT02453282Phase 3Results posted
- Study to Evaluate Efficacy & Safety of Tralokinumab in Subjects With Asthma Inadequately Controlled on CorticosteroidsCompletedNCT02449473Phase 2Results posted
- RDEA3170 Tablet and Capsule Bioavailability StudyCompletedNCT02448368Phase 1Results posted
- Pembrolizumab Alone and In Combination With Acalabrutinib (ACP-196) in Subjects With Advanced Non-small Cell Lung CancerCompletedNCT02448303Phase 2Results posted
- A Single Arm, Tolerability and Safety Phase IV Study of Fulvestrant(Faslodex® ) as 2nd Line and Later Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast CancerCompletedNCT02447328Phase 4Results posted
- Efficacy and Safety of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus ErythematosusCompletedNCT02446912Phase 3Results posted
- Efficacy and Safety of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus ErythematosusCompletedNCT02446899Phase 3Results posted
- A Bioavailability Study With Alternate Methods of Administration of Naloxegol Tablets, and SolutionCompletedNCT02446171Phase 1Results posted
- Phase II Single Arm Study of AZD9291 to Treat NSCLC Patients in Asia PacificCompletedNCT02442349Phase 2Results posted
- Study to Assess the Bioequivalence Between Ticagrelor Orodispersible Tablets and Ticagrelor Immediate-release Tablets in Japanese SubjectsCompletedNCT02436577Phase 1Results posted
- A Study to Evaluate the Safety of Rosuvastatin in Children and Adolescents With Homozygous Familial HypercholesterolemiaCompletedNCT02434497Phase 3Results posted
- Chronic Dosing Cross-Over Study to Assess the Efficacy and Safety of Glycopyrronium (PT001) in Adult Subjects With Intermittent Asthma or Mild to Moderate Persistent AsthmaCompletedNCT02433834Phase 2Results posted
- Rosuvastatin Adherence App Study in ChinaCompletedNCT02433288Not applicableResults posted
- The Pharmacokinetics and Safety of Olaparib Alone and With Paclitaxel in Chinese Patients With Advanced Solid Tumour.CompletedNCT02430311Phase 1Results posted
- Effect of Dapagliflozin on 24-hour Blood Glucose in T2DM Patients Inadequately Controlled With Either Metformin Or InsulinCompletedNCT02429258Phase 4Results posted
- Effects of Dapagliflozin 10 mg on Insulin Resistance in Patients With Type 2 Diabetes MellitusCompletedNCT02426541Phase 4Results posted
- Effect of Aclidinium/Formoterol on Lung Hyperinflation, Exercise Capacity and Physical Activity in Moderate to Severe COPD PatientsCompletedNCT02424344Phase 4Results posted
- A 52-week International, Multicenter Trial With a Long -Term Extension to Evaluate Saxagliptin With Dapagliflozin in Combination With Metformin Compared to Glimepiride in Combination With Metformin in Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin AloneCompletedNCT02419612Phase 3Results posted
- Study to Assess Functionality, Reliability, and Performance of a Pre-filled Syringe With Benralizumab Administered at HomeCompletedNCT02417961Phase 3Results posted
- A Study to Evaluate the Effect of Dapagliflozin on Blood Glucose Level and Renal Safety in Patients With Type 2 DiabetesCompletedNCT02413398Phase 3Results posted
- Affordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction StudyCompletedNCT02406677Phase 4Results posted
- A Drug-Drug Interaction Study of Lanabecestat (LY3314814) in Healthy ParticipantsCompletedNCT02406261Phase 1Results posted
- Brilinta Taiwan Post Approval Safety StudyCompletedNCT02406248Phase 4Results posted
- AZD2014 and Weekly Paclitaxel in Squamous NSCLCTerminatedNCT02403895Phase 2Results posted
- Study to Assess the Bioavailability of Ticagrelor OD Tablet vs. IR TabletCompletedNCT02400333Phase 1Results posted
- A Study to Assess the Safety of MEDI7836 in Healthy Adults.CompletedNCT02388347Phase 1Results posted
- AZD3241 PET MSA Trial, Phase 2, Randomized,12 Week Safety and Tolerability Trial With PET in MSA PatientsCompletedNCT02388295Phase 2Results posted
- ACP-196 Versus Placebo in Subjects With Rheumatoid Arthritis on Background MethotrexateCompletedNCT02387762Phase 2Results posted
- BENEFITS OF ACLIDINIUM BROMIDE IN THE RELIEF OF COPD SYMPTOMS INCLUDING COUGHCompletedNCT02375724Phase 4Results posted
- A Study to Investigate the Effect of Food on Pharmacokinetics of Total EPA and Total DHA of AZD0585 in Healthy Male Japanese SubjectsCompletedNCT02372344Phase 1Results posted